Vancomycin (Renal Dosing)
Brand names: Vancocin
Adult dose
Paediatric dose
Dose adjustments
Dose and/or interval must be extended based on eGFR. eGFR 10-50: every 24-72 hours. eGFR <10 or haemodialysis: every 48-96 hours or dose after each session (vancomycin partially removed by haemodialysis — check local protocol). AUC/MIC TDM mandatory in CKD.
No hepatic dose adjustment required — not hepatically metabolised
Neonates: 10-15 mg/kg every 6-24 hours depending on gestational age and postnatal age — TDM essential. BNFc for specific neonatal/paediatric dosing.
Clinical pearls
- AUC/MIC-guided dosing (2020 ASHP/IDSA guideline): target AUC 400-600 mg/h/L. Two-point sampling (C1 at 1h post-infusion, C2 as trough) allows AUC calculation via Bayesian software. Superior to trough-only monitoring for efficacy and safety.
- Red Man Syndrome: NOT an allergic reaction — histamine release from mast cells caused by rapid infusion. Management: slow infusion rate, pre-treat with chlorphenamine. Does NOT preclude future vancomycin use (unlike true allergy). Distinguish from true anaphylaxis.
- Haemodialysis: standard haemodialysis removes ~50% of vancomycin per session with high-flux membranes. Post-dialysis supplemental dose typically required. Trough before next session guides redosing — aim trough >10 mg/L for most indications.
- Ototoxicity risk: target troughs >20 mg/L or prolonged exposure increases ototoxicity. Baseline audiometry in patients expected on prolonged courses.
- CVVH/CVVHDF: vancomycin is highly cleared by continuous renal replacement therapy — typically requires doses every 24-48 hours with TDM guidance. Consult pharmacy.
Contraindications
- Hypersensitivity to vancomycin
- Known rapid infusion reactions without pre-treatment
Side effects
- Red Man Syndrome (histamine-mediated flushing, erythema, hypotension — infuse slowly; premedicate with antihistamine for high-risk patients)
- Nephrotoxicity (especially combined with aminoglycosides or NSAIDs)
- Ototoxicity (tinnitus, hearing loss — especially high trough levels or prolonged treatment)
- Thrombophlebitis (peripheral IV site)
- Neutropenia (prolonged courses)
Interactions
- Aminoglycosides (gentamicin, tobramycin) — additive nephrotoxicity and ototoxicity; avoid combination unless essential; TDM mandatory for both
- Loop diuretics (furosemide) — additive ototoxicity
- NSAIDs — additive nephrotoxicity
- Neuromuscular blocking agents — enhanced blockade
Monitoring
- AUC/MIC or trough levels (first trough before 4th dose with standard dosing)
- Serum creatinine/eGFR every 48-72 hours
- Full blood count (neutropenia risk on prolonged courses)
- Audiology (prolonged therapy)
- Signs of Red Man Syndrome during infusion
Reference: BNFc; BNF 90; BNFc; 2020 ASHP/IDSA/SIDP Vancomycin Consensus Guidelines; NICE NG15 (Antimicrobial Stewardship); SPC Vancocin. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
- Vancomycin Dosing Calculator · Drug Dosing
- Phenytoin Correction for Albumin / Renal Failure · Drug Dosing
- Local Anaesthetic Maximum Dose Calculator · Drug Dosing
- Thakar Score for Acute Renal Failure after Cardiac Surgery · Cardiac Surgery
- Mehran Score for Post-PCI Contrast Nephropathy · Coronary Artery Disease
- Thakar Score for AKI after Cardiac Surgery · Surgical Risk
- Hyperkalaemia Management · UK Kidney Association Guidelines 2020; NICE CKD Guidelines
- Rhabdomyolysis · Renal Association 2018; UpToDate 2024
- Hypocalcaemia (Adult) · Society for Endocrinology
- SIADH (Endocrine Perspective) · European Hyponatraemia Guidelines 2014
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Acute Kidney Injury (AKI) · KDIGO 2012 / NICE AKI 2019